GRT/shRNA therapy(Taysha Gene Therapies)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGRT/shRNA therapy(Taysha Gene Therapies)
Drug Alias NameGRT/shRNA program for neurodegenerative diseases(Taysha Gene Therapies)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaysha Gene Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Texas Southwestern Medical CenterTaysha Gene Therapies Inc
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A